000 01596 a2200469 4500
005 20250514050244.0
264 0 _c20021118
008 200211s 0 0 eng d
022 _a0312-5963
024 7 _a10.2165/00003088-200241002-00005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOllier, Céline
245 0 0 _aAbsence of interaction of fondaparinux sodium with aspirin and piroxicam in healthy male volunteers.
_h[electronic resource]
260 _bClinical pharmacokinetics
_c2002
300 _a31-7 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
650 0 4 _aAdult
650 0 4 _aAspirin
_xpharmacology
650 0 4 _aBleeding Time
650 0 4 _aCross-Over Studies
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Interactions
650 0 4 _aFibrinolytic Agents
_xblood
650 0 4 _aFondaparinux
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPartial Thromboplastin Time
650 0 4 _aPiroxicam
_xpharmacology
650 0 4 _aPlatelet Aggregation Inhibitors
_xblood
650 0 4 _aPolysaccharides
_xblood
700 1 _aFaaij, Richard A
700 1 _aSantoni, Alix
700 1 _aDuvauchelle, Thierry
700 1 _avan Haard, Paul M M
700 1 _aSchoemaker, Rik C
700 1 _aCohen, Adam F
700 1 _ade Greef, Rik
700 1 _aBurggraaf, Jacobus
773 0 _tClinical pharmacokinetics
_gvol. 41 Suppl 2
_gp. 31-7
856 4 0 _uhttps://doi.org/10.2165/00003088-200241002-00005
_zAvailable from publisher's website
999 _c12192410
_d12192410